Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2012; 7(5): e37070.
Published online 2012 May 14. doi:  10.1371/journal.pone.0037070
PMCID: PMC3351389

Lack of Cul4b, an E3 Ubiquitin Ligase Component, Leads to Embryonic Lethality and Abnormal Placental Development

Anton Wutz, Editor


Cullin-RING ligases (CRLs) complexes participate in the regulation of diverse cellular processes, including cell cycle progression, transcription, signal transduction and development. Serving as the scaffold protein, cullins are crucial for the assembly of ligase complexes, which recognize and target various substrates for proteosomal degradation. Mutations in human CUL4B, one of the eight members in cullin family, are one of the major causes of X-linked mental retardation. We here report the generation and characterization of Cul4b knockout mice, in which exons 3 to 5 were deleted. In contrast to the survival to adulthood of human hemizygous males with CUL4B null mutation, Cul4b null mouse embryos show severe developmental arrest and usually die before embryonic day 9.5 (E9.5). Accumulation of cyclin E, a CRL (CUL4B) substrate, was observed in Cul4b null embryos. Cul4b heterozygotes were recovered at a reduced ratio and exhibited a severe developmental delay. The placentas in Cul4b heterozygotes were disorganized and were impaired in vascularization, which may contribute to the developmental delay. As in human CUL4B heterozygotes, Cul4b null cells were selected against in Cul4b heterozygotes, leading to various degrees of skewed X-inactivation in different tissues. Together, our results showed that CUL4B is indispensable for embryonic development in the mouse.


Cullin-RING ligases (CRLs) complexes comprise the largest known class of ubiquitin ligases [1]. CRLs regulate diverse cellular processes, including cell cycle progression, transcription, signal transduction and development [2]. CRLs are multisubunit complexes composed of a cullin, RING protein and substrate-recognition subunit, which was linked by an adaptor. Human cullin family consists of eight members, CUL1, CUL2, CUL3, CUL4A, CUL4B, CUL5, CUL7 and PARC [3], among them, CUL4A and CUL4B have the highest degree of homology, with 83% identity in protein sequences [4]. There is only one ortholog, Cul4, in lower organisms. CUL4A CRL complexes contained Rbx1 and the adaptor protein DDB1. DDB1 interact with substrate recognition subunits, which determine the substrate specificity of the CUL4A CRL complexes [5], [6], [7], [8], [9]. The substrates of CUL4A CRL complexes include CDT1, p21, p27, p53, c-Jun, HOXA9, H3 and CHK1 that play important roles in cell cycle regulation, chromosome remodeling, and differentiation [10], [11].

Compared to CUL4A, CUL4B is less studied, and so far very few substrates of CUL4B CRL complexes have been identified [4], [12], [13], [14], [15]. However, mutations in human CUL4B appear to be a common cause of X-linked mental retardation (XLMR). To date, at least 12 families of XLMR have been reported to be attributable to base substitutions or deletions in CUL4B [16], [17], [18], [19], [20]. In addition to mental retardation, those patients also manifest short stature, abnormal gait, impaired speech and other abnormalities. These findings suggest that CUL4B and CUL4A do not necessarily play redundant roles during neurogenesis and other developmental processes.

While Cul4a knockout mice have been independently generated by several groups, they showed highly variable phenotypes depending on the nature of the mutation introduced. Homozygous deletion of exon 1 of Cul4a was first reported to result in embryonic lethality [21]. However, a recent study showed that deletion of exon 1 of Cul4a inadvertently deleted the essential Pcid2 gene located adjacent to Cul4a on the complementary strand [22]. Mice with deletion of exons 17–19 of Cul4a, on the other hand, were viable and displayed no overt developmental abnormalities, although skin-specific Cul4a ablation rendered resistance to UV-induced skin carcinogenesis [22]. Similarly, homozygous deletion of exons 4–8 of Cul4a resulted in no gross abnormalities [23]. However, the male knockout mice were sterile and exhibit severe deficiencies in spermatogenesis [23], [24]. Homozygous deletion of exons 4–8 of Cul4a is also associated with severe proliferation defects in embryonic fibroblasts and hepatocytes, and an increase in genome instability [25].

In this study, we generated Cul4b floxed mice and crossed it to EIIa-Cre transgenic mice to produce Cul4b null mice. We observed that Cul4b null mice are embryonic lethal. Cul4b null embryos displayed decreased proliferation and increased apoptosis. Cul4b heterozygotes were also affected, as reflected by their recovery at a reduced ratio at birth and by their developmental delay. Cells expressing Cul4b null allele in Cul4b heterozygous mice were selected against, to different degrees in different tissues, from early embryogenesis to early postnatal development. The embryonic lethality of Cul4b null mice, when compared to the lack of gross abnormalities in Cul4a null mice, indicated that Cul4b has diverged from Cul4a to carry out some essential and unique functions during embryogenesis.


Generation of Cul4b floxed mice

Because CUL4B-deficient cells are strongly selected against [17], we envisaged that it might be difficult to generate Cul4b-deficient embryonic stem (ES) cells via conventional knockout technology. We therefore used the Cre/loxP strategy to generate Cul4b floxed ES cells. First, a Cul4b floxed targeting vector was constructed (Fig. 1A). In this vector, exons 3–5 were floxed by two loxP sites. A neo gene flanked by two FRT sites and a TK gene were also insert into intron 5 and vector backbone, respectively, for ES cells selection.

Figure 1
Generation of Cul4b flox mice.

The targeting vector was linearized and electroporated into 129 male ES cells (RW.4) for homologous recombination. Ninety six clones were screened by long-range PCR (data not shown) and Southern blot (Fig. 1B). Two correctly targeted clones, 2G and 4E, were identified. Targeted ES cells were injected into C57BL/6J blastocysts to produce chimaeric mice, which were then used for germline transmission to produce Cul4b floxed mice.

Neither male hemizygous (Cul4bflox/Y) nor female heterozygous/homozygous (Cul4b+/flox/Cul4bflox/flox) for the Cul4b floxed allele showed any apparent phenotype, suggesting that the flox allele did not disturb the normal function of Cul4b gene. To verify that Cul4bflox can be rendered nonfunctional by the expression of Cre, due to the removal of exons 3–5, we generated brain-specific knockout mice Cul4bflox/Y;Nestin-Cre mice and sequenced the cDNA of Cul4b prepared from the brain. We observed that exon 2 was indeed spliced onto exon 6, as a result of removal of exons 3–5 (Fig. 1C). The deletion would also result in a frameshift, generating 8 missense condons followed by a stop codon (Fig. 1C, underlined). The mutant allele is thus predicted to generate a peptide of merely 28 amino acids, if it can be expressed. Thus, deletion of exons 3–5 created a null mutation. Furthermore, the Cul4b mRNA level in brains of the conditional knockout mice is much lower than that of littermate wild-type control (Fig. 1D), suggesting that the truncation mutation also resulted in nonsense-mediated decay (NMD), as observed in patients with CUL4B nonsense mutation [17]. Western blot analysis showed that Cul4b protein was nearly absent in brain tissues of conditional knockout mice (Fig. 1E). Together, these results indicate that deletion of exons 3–5 in Cul4b results in a null mutation.

Cul4b null mice are not viable

To investigate the function of Cul4b during mouse development, Cul4b floxed mice were crossed to EIIa-Cre transgenic mice to generate constitutive Cul4b null mice. The Cre transgene in the EIIa-Cre mice is driven by the adenovirus EIIa promoter and is expressed in a wide range of tissues, including germ cells. Because EIIa-Cre is not expressed in all cells (mosaic expression), Cul4b+/flox females were first crossed to EIIa-Cre+/+ males to obtain mosaic females that are Cul4b+/flox/Cul4b+/null;EIIa-Cre+/−. Mosaic females were then crossed to wild-type males to generate progeny of Cul4b knockout male mice (Cul4bnull/Y), Cul4b heterozygous females (Cul4b+/null) and wild-type mice (Cul4b+/+ and Cul4b+/Y). While Cul4b+/null females were recovered, no Cul4bnull/Y mice were present in the weaned pups (Table 1), suggesting that Cul4bnull/Y conceptuses can not develop to term or die before weaning.

Table 1
Distribution of Cul4b genotypes in progeny of Cul4b+/flox/Cul4b+/null;EIIa-Cre+/− females.

Cul4b null embryos showed early developmental arrest

To determine the exact time point when Cul4bnull/Y conceptuses die, timed mating was performed and embryos at different developmental stages were dissected. DNA was extracted from yolk sac or total embryo and used for PCR genotyping. Genotyping of E9.5, 10.5, 12.5 and 14.5 embryos showed that no Cul4bnull/Y conceptuses were recovered on 9.5 day post coitum (dpc) and beyond. Instead, a proportion of embryos, ∼25%, appeared to have been absorbed and only placentas or empty deciduas remained (Fig. 2A), suggesting that these embryos implanted but died by E9.5. Cul4b null embryos were recovered at a ratio expected of Mendelian inheritance at E7.5 and 8.5, and no empty deciduas were found at these developmental stages. However, the Cul4b null embryos were much smaller (Fig. 2B). The recovery of Cul4b null embryos at the expected Mendelian ratio indicated that the mosaic females are functionally Cul4b+/null in their capacity to transmit Cul4bnull allele.

Figure 2
Morphology and histology of Cul4b null embryos.

To gain further insight into the anomalies in the Cul4b null embryos, we performed H&E staining of paraffin-embedded sections of E7.5 embryos. While in wild-type embryos, ectoderm, mesoderm and endoderm appeared to have properly formed, the embryonic part of the cylinder was not expanded and boundaries between germ layers were indiscernible in the Cul4b null embryos (Fig. 2C), which were identified by their negative staining by anti-Cul4b antibody (see below). In addition, extraembryonic compartment in Cul4b null embryos was also underdeveloped and poorly organized (Fig. 2C). Thus, in general, the Cul4b null embryos are developmentally retarded when compared to stage-matched wild-type embryos.

Immunohistochemistry, using an anti-Cul4b antibody, showed that Cul4b was ubiquitously expressed in wild-type E7.5 embryos (Fig. 2D–2F), including ectoplacental cone, trophoblast giant cells, chorion (Fig. 2E), and the embryonic region (Fig. 2F). Expression of Cul4b in extraembryonic regions suggests that Cul4b may be involved in placental development. As expected, the Cul4b null embryos were devoid of staining by anti-Cul4b.

Because a high degree of homology exists between Cul4a and Cul4b, we also examined the expression of Cul4a in 7.5 dpc embryos. Positive staining of Cul4a was detected throughout the whole embryos (Figure S1A). Furthermore, the expression of Cul4a was not found to differ between Cul4b null and wild-type embryos, suggesting that deletion of Cul4b gene did not affect the expression of Cul4a gene. Apparently, Cul4a failed to compensate for the lack of Cul4b in early embryonic development.

Decreased proliferation and increased apoptosis in Cul4b null embryos

To investigate what causes the developmental delay of the Cul4b null embryos, we analyzed the proliferative activity and apoptosis in E7.5 embryos. The proliferation was evaluated by immunohistochemical staining of paraffin sections of E7.5 embryos for Ki67, a marker of proliferating cells. While there was a high level of proliferation in the wild-type embryos, proliferative cells were less abundant in Cul4b null embryos (Fig. 3A). BrdU incorporation assay confirmed the decrease in proliferation in Cul4b null embryos (Fig. 3B), suggesting that the proliferative activity was greatly compromised in Cul4b null embryos.

Figure 3
Decreased proliferation and increased apoptosis in Cul4b null embryos.

Apoptosis in E7.5 embryos was evaluated by TdT-mediated dUTP nick end labeling (TUNEL) assay. Apoptotic cells were rarely detected in wild-type E7.5 embryos; however, the number of apoptotic cells was remarkably increased in the Cul4b null embryos (Fig. 3C). Apoptotic cells were also observed to line along the Reichert's membrane.

It was previously reported that CUL4B can interact with cyclin E and the CUL4B immunocomplexes can polyubiquitinate cyclin E in vitro [26]. We previously showed that silencing of CUL4B could lead to increased accumulation of cyclin E [4]. To determine whether deficiency of Cul4b would also cause increased accumulation of cyclin E in the Cul4b null embryos, the cyclin E level was examined using immunohistochemistry. Indeed, cyclin E was accumulated in Cul4b null embryos compared to littermate wild-type embryos (Fig. 3D).

The levels of other known substrates of CRL4 complex, p27 and p53, were also examined in wild-type and Cul4b null embryos at 7.5 dpc. They were not found to differ between Cul4b null embryos and wild-type embryos (Figure S1BS1C), suggesting that Cul4b probably does not play a critical role in the proteosomal degradation of those proteins during embryonic development. Alternatively, Cul4a may have compensated for the lack Cul4b in lowering the levels of those substrates.

Taken together, these results suggested that the developmental delay in Cul4b null embryos is attributable to a reduction in proliferation and an increase in apoptosis.

Reduced recovery and growth retardation of Cul4b heterozygous mice

While no Cul4b null conceptuses could survive to E9.5, the Cul4b heterozygous females were also recovered at a lower than expected ratio at weaning (Table 1). This deficit was probably caused by an increased prenatal lethality in Cul4b heterozygotes, because their ratio was reduced even at E14.5. For the Cul4b heterozygotes that survive to term, they were significantly smaller than their wild-type littermates. The average body weight of heterozygous newborns (1.13±0.17 g) was much smaller than that of wild-type controls (1.79±0.12 g). However, Cul4b heterozygous mice were able to gradually catch up after birth, and the body weight difference became narrow in adults (Fig. 4A). Except for growth retardation, Cul4b heterozygous mice showed no gross abnormalities for the first 18 months.

Figure 4
Growth retardation of Cul4b heterozygous mice during embryonic development.

The fact that Cul4b heterozygous mice were smaller in size at birth but could catch up gradually suggests that developmental delay is primarily due to factor(s) that operate during prenatal development. Therefore, heterozygous embryos at different development stages were dissected and examined (Fig. 4B–4E). Cul4b heterozygous embryos were smaller than wild-type controls at all development stages examined, suggesting that growth retardation began at early developmental stage. In addition, the Cul4b heterozygous embryos appeared pale (Fig. 4D and 4E). Blood vessels on yolk sac were not well developed (Fig. 4D), and the blood flow appeared to be reduced (Fig. 4E). Poor vascularization and shortage in blood supply may have caused undernourishment in the heterozygous embryos.

Placental defects of Cul4b heterozygous embryos

To further delineate the mechanism underlying the growth retardation of Cul4b heterozygotes during prenatal development, we examined the morphology and histology of placentas at E14.5. Placentas of Cul4b heterozygous embryos appeared smaller and paler than those of wild-type (Fig. 5A). H&E staining of placental sections showed that the labyrinth layer of Cul4b heterozygous placentas was more loosely formed compared to that of wild-type controls, and was deeply invaded by the spongiotrophoblast layer, leaving the demarcation between labyrinth and spongiotrophoblast layers indiscernible (Fig. 5B, upper panels). While the network in the labyrinth layer of placentas in the wild-type was highly compacted and densely branched; the labyrinth layer in Cul4b heterozygotes was laid out very loosely (Fig. 5B, lower panels). The labyrinth and spongiotrophoblast layers were indistinguishable in the placentas of absorbed embryos.

Figure 5
Morphology and histology of placentas of wild-type, Cul4b heterozygous and absorbed embryos at 14.5 dpc.

The vascular network in placenta was further characterized by immunohistochemistry using an antibody to platelet/endothelial cell adhesion molecule-1 (PECAM), which marks endothelial cells in blood vessels. In contrast to normal placentas in which the blood vessels were well formed and uniformly distributed (Fig. 5C, left panels), PECAM staining signals in Cul4b heterozygous placentas only appeared in rather isolated regions (Fig. 5C, middle panels). Furthermore, vascular structures were not readily recognizable within the PECAM-positive islands. Only background staining of PECAM was detected in placentas of absorbed embryos (Fig. 5C, right panels).

Taken together, these results showed that the placentas of Cul4b heterozygous embryos were generally disorganized and were impaired in vascularization, which may contribute to the growth retardation during prenatal development of Cul4b heterozygous mice.

Pattern of X-chromosome inactivation (XCI) in Cul4b heterozygous mice

Because Cul4b is X-linked, Cul4b heterozygous females are functional mosaics in terms of the expression of Cul4b. The somatic cells are either Cul4b functional or null depending on the choice of the X-chromosome that becomes inactivated. In the XLMR family with CUL4B mutation, X-chromosome inactivation (XCI) was extremely skewed in peripheral blood cells of carriers, due to the selection that favors the cells in which the mutant CUL4B allele is inactivated [17], [20]. We first determined the XCI pattern in 4-month-old adult Cul4b heterozygous females by immunohistochemical analysis for Cul4b expression. If XCI were balanced in Cul4b heterozygous females, the proportion of cells expressing Cul4b should be ∼50% of that in wild-type females. On the other hand, if XCI is skewed toward Cul4b allele, as in human CUL4B heterozygous carriers, the percentage of cells expressing Cul4b should be closer to that in wild-type females. As shown in Fig. 6A, the percentages of cells expressing Cul4b in kidney, liver and lung were identical between Cul4b heterozygous females and wild-type females, suggesting that XCI is extremely skewed in those organs. XCI in hippocampus was also skewed, but to a lesser extent, since the percentage of Cul4b positive cells in heterozygotes remained lower than that in wild-type. Western blot assay showed a similar trend (Figure S2). While the expression levels of Cul4b in liver and lung in Cul4b heterozygous mice were comparable to those in wild type mice, the expression levels in cortex and hippocampus were decreased in Cul4b heterozygous mice compared to those in wild type mice.

Figure 6
Characterization of X chromosome inactivation by Cul4b expression in heterozygous mice.

The skewed XCI toward Cul4bnull-bearing chromosome could be caused either by an initiation of XCI that favors the Cul4bnull-bearing X or by a selection against Cul4bnull-expressing cells during development. To distinguish between those two possibilities, we next examined the XCI pattern in younger Cul4b heterozygous females. As shown in Fig. 6B–C, the percentages of Cul4b-expressing cells in lung were not significantly different between Cul4b heterozygous and wild-type females even in the newborn. However, the percentages of Cul4b positive cells in kidney and liver were significantly lower in heterozygotes than in wild-type (Fig. 6B–C). These results suggest that the skewed XCI is caused by a gradual selection against the Cul4b negative cells and that different organs face differential selection pressure during prenatal and postnatal development. While Cul4b null cells in lung were nearly all eliminated before birth, those cells remained in hippocampus four months after birth (Fig. 6A–C, 6E). The less stringent selection against Cul4b null cells in hippocampus is consistent with the clear difference in the Cul4b expression level between Cul4b heterozygotes and wild-type in the brain (Fig. 1D and 1E, Fig. S2).

To gain insight into the XCI pattern at embryonic stage, we examined the distribution of Cul4b-positive and –negative cells in E7.5 embryos. XCI is usually completed by E6.5 in epiblasts. As shown in Fig. 6F, Cul4b-positive and –negative cells were not evenly distributed in the embryonic regions of the E7.5 heterozygous embryos. While the two types of cells appeared in an intermingled pattern and in roughly equal proportions in some areas (middle), indicative of the randomness of XCI before selection took place, Cul4b-positive cells were predominant in other areas (right), suggesting that selection for Cul4b-positive cells started before E7.5 wherein. The differential selection in different embryonic regions at early developmental stage may contribute to the distribution pattern of Cul4b-negative cells and the selection dynamics in various tissues at later developmental stages.


The cullin members are critical for the assembly of CRL complexes that play important roles in multiple cellular processes. Lack of cullin function has indeed been shown to have severe consequences in cellular function and organism development. Disrupting either Cul1 or Cul3 genes in mice caused embryonic lethality and dysregulation of cyclin E [27], [28], [29]. Deletion of Cul7 caused neonatal lethality, growth retardation and vascular abnormality [30]. In this study, we showed that deletion of Cul4b resulted in embryonic lethality in null hemizygotes. This finding is consistent with the embryonic lethality of Cul4b mutant mice that were generated by gene trap technology [31]. In addition, Cul4b heterozygotes were recovered in deficit and those that survive to term exhibited a developmental delay. Underscoring the importance of Cul4b function is the observed skewedness of X-inactivation in Cul4b heterozygotes as a result of selection against Cul4b null cells. The severe phenotype of Cul4b null mice is in a sharp contrast to the lack of obvious phenotype in Cul4a null mice, although the two cullin members are closely related. These findings with Cul4b mutant mice, together with the development of XLMR syndrome in humans carrying CUL4B mutation, suggest that CUL4A cannot fully compensate for the absence of CUL4B activity in mammals.

While mutations in CUL4B cause mental retardation, short stature, impaired speech, and other abnormalities, the patients usually survive to adulthood. Thus, the Cul4b mutant mice are more severely affected. The mechanism underlying this species-specific difference in phenotypic severity caused by CUL4B deficiency remains to be elucidated. It is possible that certain mutations in humans may retain residual function of CUL4B and thus have less deleterious effect than the Cul4b null mutation in the mouse. However, several mutations in human CUL4B resemble null mutations. The p.R388X mutation, for example, would have truncated the whole CULLIN domain and the rest of the C-terminus [16], [17]. Moreover, this mutation caused nonsense mediated decay of CUL4B mRNA [17]. Two reported deletions in CUL4B causing XLMR would have been devoid of most of the CULLIN domain, which is essential for CRL activity [19], [20]. It should be noted that the more severe phenotype in mouse mutants of genes responsible for XLMR is not restricted to Cul4b null mice. Loss of Atrx function, which is the second most common cause of XLMR, next to fragile X gene, also resulted in early embryonic lethality in mice [32], and even deletion of Atrx just in forebrain caused perinatal lethality [33]. Targeted inactivation of Huwe1 in the CNS also resulted in neonatal lethality [34]. It is also possible that certain functions of CUL4B are redundantly carried out by CUL4A in the humans, but not in the mouse. We are tempted to speculate that because extraembryonic development is particularly affected in Cul4b null and heterozygous embryos, CUL4B is probably more critical for placental development in the mouse than in the humans. Future studies employing ablation of Cul4b in embryo proper may help resolve this issue.

We previously showed that silencing of CUL4B led to an increased accumulation of cyclin E and a reduced cell proliferation that was accompanied by a prolonged S phase [4]. Correspondingly, we found that Cul4b null embryonic cells are also accompanied by an increased accumulation of cyclin E. The inverse relationship between CUL4B and cyclin E was also observed in mouse liver in which Cul4b was ablated (unpublished data). While several recent studies showed that excessive cyclin E may play negative roles in cell proliferation [35], [36], it remains to be determined whether the developmental arrest in Cul4b null embryos is caused by excessive cyclin E.

Unexpectedly, we observed that Cul4b heterozygous mice were also affected, as reflected by their recovery at a lower than expected ratio and by their remarkable developmental delay at birth. They began to catch up with their wild-type littermates after birth. This delay was probably caused by the disorganization and impaired vascularization in placenta. These data suggested that Cul4b played an important role in placental development, which is crucial for nutrition and oxygen supply to the developing embryos. Indeed, CUL7, another cullin family member, was found to be over-expressed in placentas associated with intra-uterine growth restriction [37]. Furthermore, targeted disruption of Cul7 gene resulted in abnormal vascular morphogenesis in placenta [30], a phenotype similar to what we observed in Cul4b heterozygous embryos. This developmental delay in Cul4b heterozygous mice is in contrast to human carriers, whose body sizes are in normal range in their childhood [17]. While it is possible that the proliferative disadvantage of the Cul4b null cells during late prenatal development may also contribute to the developmental delay of Cul4b heterozygous females, we think it less likely because selection against Cul4b null cells started rather early during embryogenesis, and the Cul4b functional cells would quickly compensate for the loss of the Cul4b null cells.

As reported for Atrx heterozygous mice in which selection against Atrx null cells followed different dynamics in different tissues [38], the selection pressure against Cul4b null cells also varies among different organs. While the percentages of Cul4b-expressing cells in lung were not significantly different between Cul4b heterozygous and wild-type females even in the newborn, a significant proportion of Cul4b null cells still lingered in hippocampus four months after birth. The different selection pressure of Cul4b null cells may reflect differential requirement of Cul4b function in proliferation and maintenance in various organs.

In summary, we showed that Cul4b null mice were embryonic lethal at around 8.5 dpc. Cul4b null embryos showed a reduction in proliferative capacity and an increase in apoptosis. Cul4b heterozygous mice exhibited prenatal and early postnatal growth retardation that may be related to defective placental development. Our results illustrate the functional importance of Cul4b gene in mouse embryonic development. The Cul4b floxed mice should serve as a powerful tool for future study of Cul4b function in various cellular processes and in various tissues.

Materials and Methods

Generation of mice with the floxed Cul4b gene

The animal work was approved by Animal Use Committee, Shandong University School of Medicine (Approval number: ECAESDUSM2008005). Cul4b floxed mice were generated at National Resource Center of Mutant Mice/Model Animal Research Center of Nanjing University. First, a Cul4b floxed targeting vector was constructed. Briefly, a 14.5 Kb DNA fragment of the mouse Cul4b gene, spanning the region from intron 2 to intron 5, was subcloned from a BAC clone (BMQ-455M17) into a vector which contained a TK cassette. A loxP site was inserted into intron 2 of Cul4b gene and a FRT-neo-FRT-loxP cassette was inserted into intron 5. (Fig. 1A)

The floxed targeting vector was linearized using NotI restriction enzyme and electroporated into 129 male ES cells (RW.4, obtained from ATCC), followed by selection in culture medium containing G418 and ganciclovir. To identify correctly targeted clones, 96 clones were selected, replicated and screened by long-range PCR using DNA isolated from each clone. Positive clones identified were further confirmed by Southern blot analysis. Southern blot of DNA digested with BamHI restriction enzyme with the 5′ probe that hybridizes with the upstream of the targeted region yielded a 14.4 kb fragment for the wild-type allele and a 10 kb fragment for the targeted allele. Analysis using XbaI restriction enzyme with the 3′ probe that hybridizes with the downstream of the target region revealed a 20 kb fragment for the wild-type allele and a 10 kb fragment for the targeted allele.

Correctly targeted ES cells were injected into the blastocysts of E3.5 embryos from hyperovulated C57BL/6J mice. Surviving blastocysts were transferred into the oviducts of pseudopregnant recipient females to produce chimaeric mice, which were further crossed with wild-type mice for germline transmission to produce Cul4b floxed mice.

Generation of constitutive and brain-specific Cul4b knock-out mice

To produce mice null for Cul4b gene, Cul4b floxed mice were crossed with EIIa-Cre transgenic mice [39], in which Cre transgene was under the control of the adenovirus EIIa promoter that drives the expression of Cre recombinase in a wide range of tissues, including the germ cells that transmit the genetic alteration to progeny. Due to the mosaic pattern of Cre expression in EIIa-Cre transgenic mice, deletion of the floxed fragment is usually not achieved in all the somatic cells, thus commonly resulting in genetically mosaic mice. To avoid mosaicism, the following strategy was used. Cul4b+/flox females were crossed with EIIa-Cre+/+ males to obtain mosaic females that are Cul4b+/flox/Cul4b+/null;EIIa-Cre+/−. Female mosaic mice were subsequently crossed with wild-type male mice. A germ cell produced by the mosaic may carry either Cul4bnull or Cul4bflox allele, but not both. The Cul4bnull type of germ cells would give rise to progeny that were Cul4b knockout males (Cul4bnull/Y) and Cul4b heterozygous females (Cul4b+/null). The Cul4bflox type of germ cells, on the other hand, will give rise to Cul4bflox/Y males or Cul4b+/flox females. As shown in the Results, even though the females were supposed to be Cul4b+/flox/Cul4b+/null;EIIa-Cre+/−, no Cul4bflox allele was detected in the progeny, suggesting that Cul4bflox allele is also converted into Cul4bnull during germline transmission.

To produce conditional knock-out mice in which Cul4b gene was specific deleted in brain tissue, Cul4b+/flox female mice were cross with Nestin-Cre transgenic mice [40], in which Cre recombinase was under the control of the promoter and enhancer of rat nestin that was primarily expressed in the nervous system. These crosses would be expected to yield wild-type females (Cul4b+/+;Nestin-Cre+/−), heterozygous females (Cul4b+/flox;Nestin-Cre+/−), wild-type males (Cul4b+/Y;Nestin-Cre+/−), and conditional knock-out males (Cul4bflox/Y;Nestin-Cre+/−) in a ratio of 1∶1∶1∶1.

The EIIa-Cre and Nestin-Cre transgenic mice were purchased form model animal research center of Nanjing University. All experiments involving animals were conducted in compliance with national regulations and by protocols approved by institutional animal care and use committee.

PCR genotyping

Genomic DNA was extracted from tails, whole embryos or yolk sac, and used for genotyping by PCR analysis. For the genotyping of Cul4b flox mice, primers p01 (5′-ACAGGTATTTGCCAGTGCTGTC-3′) and p02 (5′-TTCTGTTACCTTCCTACCGAGAG-3′), flanking the loxP site in intron 2, were used to amplify Cul4b flox allele (501 bp) and wild-type allele (383 bp) (Fig. S3A). For the genotyping of Cul4b null mice, primers p03 (5′-GACTTTACAGAGTTTATCGTTGGT-3′) and p04 (5′-ACAAGAGGGAGATGGTCAGC-3′) were used for detection of the Cul4b null allele (498 bp), and primers p05 (5′-AGCACGCAGGCACATAAACG-3′) and p06 (5′-CTGGAACCCCAAGGCAGAAG-3′) were used for detection of the Cul4b wild-type allele (321 bp) (Fig. S3B).

Reverse transcription PCR and real-time RT-PCR

Total RNA from the brain tissues of 2-week mice of different genotypes was isolated using Trizol reagent (Invitrogen, Carlsbad, CA, USA), and treated with RQ1 RNase-Free DNase (Promega) to eliminate genomic DNA contamination. Freshly isolated RNA was reverse transcribed to generate cDNA using Super Script first-strand synthesis system (Invitrogen) following the manufacturer's recommendations. Cul4b gene was amplified by PCR using cDNA as template, and PCR product were sequenced. Real-time PCR was performed for quantitation of Cul4b mRNA using the TagMan 7500 instrument (PE Applied Biosystems). The mRNA levels of Cul4b was measured by SYBR Green I assay using SYBR Green Universal PCR Master Mix (Applied Bilsystems). Mice Gapdh was used as endogenous control. The sequences of the primers were for Cul4b, 5′-TATTAGTTGGCAAGAGTGCAT-3′ and 5′-CCAGTAACCCATTGTCAGGAT-3′, and for Gapdh, 5′-AGGTCGGTGTGAACGGATTTG-3′ and 5′-TGTAGACCATGTAGTTGAGGTCA-3′. Four independent measurements per sample were performed. The quantified individual RNA expression levels were normalized to Gapdh.

Western blot

Protein was extracted from brain tissues of 2-week mice of different genotypes. The concentration of tissue lysates was determined by using the BCA kit (Pierce, Rockford, IL, USA). Then equal amounts (50 µg) of total protein was subjected to 12% SDS-polyacrylamide gel for electrophoresis, followed by blotting onto polyvinylidene difluoride (PVDF) membranes (Amersham Pharmacia Biotech), and incubated with the anti-Cul4b primary antibody (Sigma; used at 1∶1,000 dilution) overnight at 4°C. After washing, the membranes were incubated with a horseradish peroxidase (HRP) conjugated secondary antibody (Jackson ImmunoResearch; 1∶10,000 dilution) for 1 hour at room temperature. Chemiluminescence detection was performed by ECL PLUS kit (Amersham Pharmacia Biotech). The membranes then were exposed to X-Omat Kodak film (Perkin Elmer) to visualize the bands. GAPDH was used as a loading control (Sigma, 1∶5,000 dilution).

Timed pregnancies

To generate timed pregnancies, female mice were injected intraperitoneally with pregnant mare's serum gonadotropin (PMSG, 5 IU per animal), followed by injection with human chorionic gonadotropin (HCG, 5 IU per animal) 48 hours later and mating overnight with males. The next morning, males were removed and females were examined for the presence of vaginal plugs. Females were sacrificed at 7.5, 8.5, 9.5, 10.5, 12.5 or 14.5 dpc and the embryos were dissected under a dissection microscope.


Specimens were dissected and fixed in 4% paraformaldehyde at 4°C overnight, followed by two different processes: (1) tissues of adult mice were cryo-sectioned for immunohistochemistry; (2) embryos were dehydrated, embedded in paraffin, and then sectioned for hematoxylin and eosin (H&E) staining, immunohistochemistry and TUNEL assay.


After deparaffinization and rehydration, the sections were boiled in citrate sodium buffer for 15 minutes for antigen recovery, and immersed in 3% H2O2 for 10 minutes to quench endogenous peroxidase. Sections were then blocked with 10% serum at 37°C for 1 hour. The primary antibodies were added to the sections and incubated overnight at 4°C. The primary antibodies used are anti-Cul4b (Sigma, 1∶1,000 dilution), anti-ki67 (Abcam, 1∶200 dilution), anti-cyclin E (Abcam, 1∶200 dilution), anti-PECAM (Abcam, 1∶50 dilution), anti-Cul4a (Abcam, 1∶200 dilution), anti-p27 (Santa Cruz, 1∶200 dilution), and anti-p53 (Santa Cruz, 1∶200 dilution).

After washing, the sections were coated with a horseradish peroxidase (HRP) conjugated second antibody (Jackson ImmunoResearch; 1∶200 dilution) and then incubated at 37°C for 1 hour. The DAB was used to visualize immunoreactions sites. Sections were counterstained with hematoxylin and mounted on glass slides. Negative controls were obtained by substituting the primary antibody with normal serum.

BrdU incorporation and immunofluorescence

For labeling of cells in S phase, BrdU (Sigma-Aldrich) was injected intraperitoneally into pregnant mice at 7.5 dpc, with 100 mg per Kg body weight. Animals were sacrificed after 2 hours by cervical dislocation and the embryos were recovered in ice cold PBS and were fixed in 4% paraformaldehyde. Incorporation of modified nucleotide was detected by staining with an anti-BrdU primary antibody (Abcam, 1∶100 dilution) and Rhodamin-labeled secondary antibody (Jackson ImmunoResearch; 1∶100 dilution). After staining, the slides were counterstained with DAPI and visualized under a fluorescence microscopy.

TUNEL assay

TUNEL assay was performed using the In Situ Cell Death Detection Kit, TMR red (Roche) following the manufacturer's recommendations. After labeling, the slides were counterstained with DAPI and visualized under a fluorescence microscopy.

Statistical Analysis

Data were expressed as the mean±SD. Data from the two groups were evaluated statistically by a two-tailed unpaired t test using SPSS13.0 for any significant differences. A p value of less than 0.05 was considered statistically significant.

Supporting Information

Figure S1

Expression of Cul4a, p27 and p53 in wild-type and Cul4b null embryos at 7.5 dpc. Paraffin sections of wild-type and Cul4b null embryos at 7.5 dpc were stained with an antibody against Cul4a (A), p27 (B) and p53 (C). Sections were counterstained with haematoxylin. Lower panels (100×) are the higher magnification of the upper panels (20×).


Figure S2

Western blot analysis of Cul4b levels. Proteins prepared from tissues of wild-type and heterozygous mice at 4 months were subjected to Western blot analysis using an anti-Cul4b antibody. Gapdh was used as a loading control.


Figure S3

PCR genotyping of Cul4b flox mice and Cul4b null mice. (A) PCR genotyping analysis of tail DNA from wild-type (WT), Cul4b flox and heterozygous (Het) mice. (B) PCR genotyping analysis of wild-type mice (Cul4b+/+ and Cul4b+/Y), Cul4b knockout male mice (Cul4bnull/Y) and Cul4b heterozygous female mice (Cul4b+/null). The null allele can only be amplified by primers p03 and p04 when exons 3–5 are deleted.



We thank Dr. Jing Hao for technical advice on sectioning of early mouse embryos.


Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by National Basic Research Program of China [2011CB966200] and National Natural Science Foundation of China [30830065, 30900804 and 81101522]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol. 2005;6:9–20. [PubMed]
2. Bosu DR, Kipreos ET. Cullin-RING ubiquitin ligases: global regulation and activation cycles. Cell Div. 2008;3:7. [PMC free article] [PubMed]
3. Sarikas A, Hartmann T, Pan ZQ. The cullin protein family. Genome Biol. 2011;12:220. [PMC free article] [PubMed]
4. Zou Y, Mi J, Cui J, Lu D, Zhang X, et al. Characterization of nuclear localization signal in the N terminus of CUL4B and its essential role in cyclin E degradation and cell cycle progression. J Biol Chem. 2009;284:33320–33332. [PMC free article] [PubMed]
5. Higa LA, Zhang H. Stealing the spotlight: CUL4-DDB1 ubiquitin ligase docks WD40-repeat proteins to destroy. Cell Div. 2007;2:5. [PMC free article] [PubMed]
6. Angers S, Li T, Yi X, MacCoss MJ, Moon RT, et al. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature. 2006;443:590–593. [PubMed]
7. Higa LA, Wu M, Ye T, Kobayashi R, Sun H, et al. CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat Cell Biol. 2006;8:1277–1283. [PubMed]
8. He YJ, McCall CM, Hu J, Zeng Y, Xiong Y. DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases. Genes Dev. 2006;20:2949–2954. [PMC free article] [PubMed]
9. Jin J, Arias EE, Chen J, Harper JW, Walter JC. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell. 2006;23:709–721. [PubMed]
10. Leung-Pineda V, Huh J, Piwnica-Worms H. DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res. 2009;69:2630–2637. [PMC free article] [PubMed]
11. Waning DL, Li B, Jia N, Naaldijk Y, Goebel WS, et al. Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis. Blood. 2008;112:320–329. [PMC free article] [PubMed]
12. Nakagawa T, Xiong Y. X-Linked Mental Retardation Gene CUL4B Targets Ubiquitylation of H3K4 Methyltransferase Component WDR5 and Regulates Neuronal Gene Expression. Mol Cell. 2011;43:381–391. [PMC free article] [PubMed]
13. Li X, Lu D, He F, Zhou H, Liu Q, et al. Cullin 4B protein ubiquitin ligase targets peroxiredoxin III for degradation. J Biol Chem. 2011;286:32344–32354. [PMC free article] [PubMed]
14. Kerzendorfer C, Whibley A, Carpenter G, Outwin E, Chiang SC, et al. Mutations in Cullin 4B result in a human syndrome associated with increased camptothecin-induced topoisomerase I-dependent DNA breaks. Hum Mol Genet. 2010;19:1324–1334. [PMC free article] [PubMed]
15. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature. 2007;446:562–566. [PubMed]
16. Tarpey PS, Raymond FL, O'Meara S, Edkins S, Teague J, et al. Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am J Hum Genet. 2007;80:345–352. [PMC free article] [PubMed]
17. Zou Y, Liu Q, Chen B, Zhang X, Guo C, et al. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am J Hum Genet. 2007;80:561–566. [PMC free article] [PubMed]
18. Badura-Stronka M, Jamsheer A, Materna-Kiryluk A, Sowinska A, Kiryluk K, et al. A novel nonsense mutation in CUL4B gene in three brothers with X-linked mental retardation syndrome. Clin Genet. 2010;77:141–144. [PubMed]
19. Isidor B, Pichon O, Baron S, David A, Le Caignec C. Deletion of the CUL4B gene in a boy with mental retardation, minor facial anomalies, short stature, hypogonadism, and ataxia. Am J Med Genet A. 2010;152A:175–180. [PubMed]
20. Ravn K, Lindquist S, Nielsen K, Dahm T, Tumer Z. Clin Genet; 2012. Deletion of CUL4B leads to concordant phenotype in a monozygotic twin pair. [PubMed]
21. Li B, Ruiz JC, Chun KT. CUL-4A is critical for early embryonic development. Mol Cell Biol. 2002;22:4997–5005. [PMC free article] [PubMed]
22. Liu L, Lee S, Zhang J, Peters SB, Hannah J, et al. CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis. Mol Cell. 2009;34:451–460. [PMC free article] [PubMed]
23. Kopanja D, Roy N, Stoyanova T, Hess RA, Bagchi S, et al. Cul4A is essential for spermatogenesis and male fertility. Dev Biol. 2011;352:278–287. [PMC free article] [PubMed]
24. Yin Y, Lin C, Kim ST, Roig I, Chen H, et al. The E3 ubiquitin ligase Cullin 4A regulates meiotic progression in mouse spermatogenesis. Dev Biol. 2011;356:51–62. [PMC free article] [PubMed]
25. Kopanja D, Stoyanova T, Okur MN, Huang E, Bagchi S, et al. Proliferation defects and genome instability in cells lacking Cul4A. Oncogene. 2009;28:2456–2465. [PMC free article] [PubMed]
26. Higa LA, Yang X, Zheng J, Banks D, Wu M, et al. Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27Kip1 and cyclin E degradation. Cell Cycle. 2006;5:71–77. [PubMed]
27. Dealy MJ, Nguyen KV, Lo J, Gstaiger M, Krek W, et al. Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E. Nat Genet. 1999;23:245–248. [PubMed]
28. Singer JD, Gurian-West M, Clurman B, Roberts JM. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 1999;13:2375–2387. [PMC free article] [PubMed]
29. Wang Y, Penfold S, Tang X, Hattori N, Riley P, et al. Deletion of the Cul1 gene in mice causes arrest in early embryogenesis and accumulation of cyclin E. Curr Biol. 1999;9:1191–1194. [PubMed]
30. Arai T, Kasper JS, Skaar JR, Ali SH, Takahashi C, et al. Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis. Proc Natl Acad Sci U S A. 2003;100:9855–9860. [PMC free article] [PubMed]
31. Cox BJ, Vollmer M, Tamplin O, Lu M, Biechele S, et al. Phenotypic annotation of the mouse X chromosome. Genome Res. 2010;20:1154–1164. [PMC free article] [PubMed]
32. Garrick D, Sharpe JA, Arkell R, Dobbie L, Smith AJ, et al. Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet. 2006;2:e58. [PMC free article] [PubMed]
33. Berube NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, et al. The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clin Invest. 2005;115:258–267. [PMC free article] [PubMed]
34. Zhao X, D DA, Lim WK, Brahmachary M, Carro MS, et al. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev Cell. 2009;17:210–221. [PMC free article] [PubMed]
35. Doronkin S, Djagaeva I, Beckendorf SK. The COP9 signalosome promotes degradation of Cyclin E during early Drosophila oogenesis. Dev Cell. 2003;4:699–710. [PubMed]
36. Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature. 1999;401:297–300. [PubMed]
37. Gascoin-Lachambre G, Buffat C, Rebourcet R, Chelbi ST, Rigourd V, et al. Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations. Placenta. 2010;31:151–157. [PubMed]
38. Muers MR, Sharpe JA, Garrick D, Sloane-Stanley J, Nolan PM, et al. Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model. Am J Hum Genet. 2007;80:1138–1149. [PMC free article] [PubMed]
39. Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A. 1996;93:5860–5865. [PMC free article] [PubMed]
40. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet. 1999;23:99–103. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Gene
    Gene records that cite the current articles. Citations in Gene are added manually by NCBI or imported from outside public resources.
  • Gene (nucleotide)
    Gene (nucleotide)
    Records in Gene identified from shared sequence and PMC links.
  • GEO Profiles
    GEO Profiles
    Gene Expression Omnibus (GEO) Profiles of molecular abundance data. The current articles are references on the Gene record associated with the GEO profile.
  • HomoloGene
    HomoloGene clusters of homologous genes and sequences that cite the current articles. These are references on the Gene and sequence records in the HomoloGene entry.
  • MedGen
    Related information in MedGen
  • Nucleotide
    Primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
  • Protein
    Protein translation features of primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...